• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同活化部分凝血活酶时间试剂对轻度凝血因子缺乏的体外敏感性

In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.

作者信息

Toulon P, Eloit Y, Smahi M, Sigaud C, Jambou D, Fischer F, Appert-Flory A

机构信息

Faculté de Médecine, Laboratoire d'Hématologie, Université Nice Sophia-Antipolis, Nice, France.

CHU, Hôpital Pasteur, Service d'Hématologie Biologique, Nice, France.

出版信息

Int J Lab Hematol. 2016 Aug;38(4):389-96. doi: 10.1111/ijlh.12499. Epub 2016 May 17.

DOI:10.1111/ijlh.12499
PMID:27185477
Abstract

INTRODUCTION

Activated partial thromboplastin time (aPTT) is a routine clotting assay that is widely used to globally screen for coagulation abnormalities. It is commonly admitted that a prolonged test result, may trigger the need for specific assays to be performed, particularly factor measurement. However, the sensitivity of aPTT reagents to deficiencies of clotting factors varies.

METHODS

We evaluated, according to the recommendation of the CLSI H47-A2 guideline, the responsiveness to single factor levels of five aPTT reagents by using factor-deficient plasmas spiked with a calibration plasma to produce individual factor activities ranging from <1 to ~100 Unit (U)/dL. Test results were expressed as the sample-to-control ratio, the latter was defined as the clotting time obtained in the calibration plasma containing ~100 U/dL factor activity. The factor activity producing a prolongation of aPTT above the upper limit of its specific normal range (in ratio) was assigned as the factor responsiveness in U/dL to that reagent.

RESULTS

Responsiveness ranged from 34 to 47 U/dL to

FVIII

C, from 18 to 57 U/dL to FIX, from 38 to 52 U/dL to FXI, from 29 to 50 U/dL to FXII, from 40 and 59 U/dL to FV, from 7.5 to 49 U/dL to FX, and from 9.1 to 10.5 U/dL to FII.

CONCLUSIONS

These results suggest that the sensitivity of the tested aPTT reagents to single factor deficiency is highly variable. Moreover, for one given aPTT reagent, its sensitivity was very different depending on the deficient factor. This must be considered when analyzing clinical materials.

摘要

引言

活化部分凝血活酶时间(aPTT)是一种常规凝血检测方法,广泛用于全面筛查凝血异常。人们普遍认为,检测结果延长可能会引发进行特定检测的需求,尤其是因子测定。然而,aPTT试剂对凝血因子缺乏的敏感性各不相同。

方法

根据CLSI H47-A2指南的建议,我们通过向缺乏因子的血浆中加入校准血浆来产生个体因子活性范围从<1至约100单位(U)/dL,评估了五种aPTT试剂对单一因子水平的反应性。检测结果表示为样本与对照的比值,后者定义为在含有约100 U/dL因子活性的校准血浆中获得的凝血时间。使aPTT延长超过其特定正常范围上限(以比值计)的因子活性被指定为该试剂以U/dL计的因子反应性。

结果

对FVIII:C的反应性范围为34至47 U/dL,对FIX为18至57 U/dL,对FXI为38至52 U/dL,对FXII为29至50 U/dL,对FV为40至59 U/dL,对FX为7.5至49 U/dL,对FII为9.1至10.5 U/dL。

结论

这些结果表明,所测试的aPTT试剂对单一因子缺乏的敏感性差异很大。此外,对于一种给定的aPTT试剂,其敏感性因缺乏的因子而异。在分析临床材料时必须考虑这一点。

相似文献

1
In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.不同活化部分凝血活酶时间试剂对轻度凝血因子缺乏的体外敏感性
Int J Lab Hematol. 2016 Aug;38(4):389-96. doi: 10.1111/ijlh.12499. Epub 2016 May 17.
2
Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?按照2008年CLSI H47 - A2指南计算的PT和APTT对凝血因子缺乏的敏感度是否反映了患者血浆中发现的凝血因子缺乏情况?
Int J Lab Hematol. 2015 Dec;37(6):853-60. doi: 10.1111/ijlh.12424. Epub 2015 Sep 4.
3
APTT critical value establishment in four different reagent/instrument systems based on single factor deficiencies.基于单因素缺乏的四种不同试剂/仪器系统中 APTT 危急值的建立。
Ann Hematol. 2024 Aug;103(8):3219-3227. doi: 10.1007/s00277-024-05718-8. Epub 2024 Jun 27.
4
Determination of APTT factor sensitivity--the misguiding guideline.活化部分凝血活酶时间(APTT)因子敏感性的确定——误导性的指南。
Int J Lab Hematol. 2013 Dec;35(6):652-7. doi: 10.1111/ijlh.12109. Epub 2013 May 30.
5
Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.新型具有穿刺帽的全自动凝血分析仪Q分析仪的评估,该分析仪具备凝血、发色底物法及免疫比浊检测功能。
Blood Coagul Fibrinolysis. 2013 Jan;24(1):28-34. doi: 10.1097/MBC.0b013e3283597621.
6
Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.活化部分凝血活酶时间。11种试剂用于筛查轻度甲型血友病的多中心评估。
Scand J Haematol. 1980 Oct;25(4):308-17.
7
Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays.重组凝血因子 IX 与重组白蛋白融合蛋白在一期凝固测定中的性能。
J Thromb Haemost. 2019 Jan;17(1):138-148. doi: 10.1111/jth.14332. Epub 2018 Dec 16.
8
Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants.活化部分凝血活酶时间(APTT)检测:确定试剂对因子缺乏、肝素和狼疮抗凝物的敏感性
Methods Mol Biol. 2017;1646:75-83. doi: 10.1007/978-1-4939-7196-1_5.
9
Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.关于活化部分凝血活酶时间试剂选择和使用的建议。
Am J Clin Pathol. 2012 Jun;137(6):904-8. doi: 10.1309/AJCP3J1ZKYBFQXJM.
10
Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.应用直接活化部分凝血活酶时间比值(PlatelinLS/ActinFS)能够在儿科术前筛查中,针对活化部分凝血活酶时间单独延长的情况,快速且可靠地识别出与出血相关的因子缺乏或狼疮抗凝物。
Eur J Haematol. 2016 Jun;96(6):578-85. doi: 10.1111/ejh.12634. Epub 2015 Jul 29.

引用本文的文献

1
Impact of asundexian on a panel of coagulation assays.阿孙地昔对一组凝血检测的影响。
Res Pract Thromb Haemost. 2025 Jun 24;9(5):102950. doi: 10.1016/j.rpth.2025.102950. eCollection 2025 Jul.
2
Hemostasis Laboratory Diagnostics in Newborns.新生儿止血实验室诊断
J Clin Med. 2025 Jul 17;14(14):5068. doi: 10.3390/jcm14145068.
3
Use of activated partial thrombin time and prothrombin time for quality assessment of fresh frozen plasma.使用活化部分凝血活酶时间和凝血酶原时间评估新鲜冰冻血浆的质量。
Int J Hematol. 2025 Apr 12. doi: 10.1007/s12185-025-03984-4.
4
Laboratory and Molecular Diagnosis of Factor XI Deficiency.因子 XI 缺乏症的实验室及分子诊断
Semin Thromb Hemost. 2025 Mar;51(2):145-154. doi: 10.1055/s-0044-1792033. Epub 2024 Nov 4.
5
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient.严重出血性凝血功能障碍患者的围手术期处理注意事项。
Anesthesiology. 2023 May 1;138(5):535-560. doi: 10.1097/ALN.0000000000004520.
6
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments.VIII 因子和 IX 因子活性测定在血友病诊断及相关治疗中的应用。
Semin Thromb Hemost. 2023 Sep;49(6):609-620. doi: 10.1055/s-0042-1758870. Epub 2022 Dec 6.
7
Factor XI as a target for preventing venous thromboembolism.将因子XI作为预防静脉血栓栓塞的靶点。
J Thromb Haemost. 2022 Mar;20(3):550-555. doi: 10.1111/jth.15628. Epub 2022 Jan 12.
8
Cryptogenic oozers and bruisers.隐匿性渗出性淤斑和瘀斑性淤斑。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):85-91. doi: 10.1182/hematology.2021000236.
9
Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B.在血友病 A 和 B 中使用显色法与一步法因子活性测定的临床效用和影响。
Eur J Haematol. 2020 Jan;104(1):3-14. doi: 10.1111/ejh.13339. Epub 2019 Nov 13.
10
Establishing a reference range for thromboelastograph parameters in the neonatal period.建立新生儿期血栓弹力图参数的参考范围。
Int J Lab Hematol. 2019 Aug;41(4):530-535. doi: 10.1111/ijlh.13043. Epub 2019 May 7.